MEDX Stock Overview
medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
medmix AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF15.30 |
| 52 Week High | CHF26.75 |
| 52 Week Low | CHF14.40 |
| Beta | 0.78 |
| 1 Month Change | -5.20% |
| 3 Month Change | -11.87% |
| 1 Year Change | -21.22% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -65.23% |
Recent News & Updates
Recent updates
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return
Dec 19
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued
Oct 27Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital
Aug 16There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings
Feb 28medmix (VTX:MEDX) May Have Issues Allocating Its Capital
Jan 14Shareholder Returns
| MEDX | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 0.5% | -3.6% | -0.4% |
| 1Y | -21.2% | -1.2% | -4.5% |
Return vs Industry: MEDX underperformed the Swiss Medical Equipment industry which returned -1% over the past year.
Return vs Market: MEDX underperformed the Swiss Market which returned -4.2% over the past year.
Price Volatility
| MEDX volatility | |
|---|---|
| MEDX Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in CH Market | 7.4% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: MEDX has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 2,658 | Girts Cimermans | www.medmix.swiss |
medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures.
medmix AG Fundamentals Summary
| MEDX fundamental statistics | |
|---|---|
| Market cap | CHF623.96m |
| Earnings (TTM) | CHF300.00k |
| Revenue (TTM) | CHF486.60m |
2,080x
P/E Ratio1.3x
P/S RatioIs MEDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDX income statement (TTM) | |
|---|---|
| Revenue | CHF486.60m |
| Cost of Revenue | CHF328.90m |
| Gross Profit | CHF157.70m |
| Other Expenses | CHF157.40m |
| Earnings | CHF300.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 18, 2024
| Earnings per share (EPS) | 0.0074 |
| Gross Margin | 32.41% |
| Net Profit Margin | 0.062% |
| Debt/Equity Ratio | 59.2% |
How did MEDX perform over the long term?
See historical performance and comparison